Fraune, C., Harms, L., Büscheck, F., Höflmayer, D., Tsourlakis, M. C., Clauditz, T. S., . . . Schroeder, C. (2020). Upregulation of the transcription factor TFAP2D is associated with aggressive tumor phenotype in prostate cancer lacking the TMPRSS2: ERG fusion. Mol Med.
Style de citation ChicagoFraune, Christoph, et al. "Upregulation of the Transcription Factor TFAP2D Is Associated With Aggressive Tumor Phenotype in Prostate Cancer Lacking the TMPRSS2: ERG Fusion." Mol Med 2020.
Style de citation MLAFraune, Christoph, et al. "Upregulation of the Transcription Factor TFAP2D Is Associated With Aggressive Tumor Phenotype in Prostate Cancer Lacking the TMPRSS2: ERG Fusion." Mol Med 2020.
Attention : ces citations peuvent ne pas être correctes à 100%.